Obesity directly affects kidney health and influences chronic kidney disease (CKD) risk and progression through contributing ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Weight-loss jabs are “not the holy grail”, the NHS medical director has said ...

A group of health professionals have called for a review of obesity management services in light of increased public demand ...

Weight loss jabs are not a “holy grail” and will not solve the obesity crisis on their own, England’s top doctor has said.

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

ROACH: I am 5 feet, 1 inch tall, weigh 200 pounds, and have found it next to impossible to lose weight, even though I'm active. I swim, walk, or do yoga almost every day. I avoid most processed foods ...

Health secretary Wes Streeting has said weight-loss jabs like Wegovy could be given to those who are unemployed ...